Shanghai, China

Wing Shun Cheung

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.8

ph-index = 1


Location History:

  • Shanghai, CN (2021 - 2023)
  • Hoboken, NJ (US) (2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Wing Shun Cheung: Innovator in Pharmaceutical Compounds

Introduction

Wing Shun Cheung is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical health issues. With a total of 5 patents, his work has the potential to impact the treatment of various diseases.

Latest Patents

Cheung's latest patents include innovative compounds such as pyrazolopyridinone compounds. These compounds are designed for use as FGFR (fibroblast growth factor receptor) inhibitors, which are crucial in the treatment of diseases like cancer. Another significant patent involves heteroaryldihydropyrimidine derivatives, which are aimed at treating hepatitis B infections. This patent outlines compounds that can inhibit, suppress, or prevent HBV infection, showcasing Cheung's commitment to addressing pressing health concerns.

Career Highlights

Throughout his career, Wing Shun Cheung has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Janssen Pharmaceutica and Janssen Sciences Ireland Unlimited Company. His experience in these organizations has allowed him to collaborate on groundbreaking research and development projects.

Collaborations

Cheung has worked alongside talented individuals such as Zhao-Kui Wan and Qian Liu. Their collaborative efforts have contributed to the advancement of innovative pharmaceutical solutions.

Conclusion

Wing Shun Cheung's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to pave the way for advancements in the treatment of critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…